The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary localized malignant PEComa treated with surgery: A report of a large series of patients treated in a referral institution.
 
Roberta Sanfilippo
Consulting or Advisory Role - Boehringer Ingelheim; RAIN (Inst)
Research Funding - Advenchen Laboratories (Inst); Amgen/Dompé (Inst); AORG Pharmaceuticals (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Daiichi-Sankyo (Inst); Deciphera (Inst); Eisai (Inst); Epizyme (Inst); Foghorn Therapeutics (Inst); GlaxoSmithKline (Inst); Hutchison MediPharma (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PTC Therapeutics (Inst); RAIN (Inst); SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Rosalba Miceli
Honoraria - Boehringer Ingelheim
 
Chiara Fabbroni
No Relationships to Disclose
 
Marco Fiore
No Relationships to Disclose
 
Chiara Colombo
No Relationships to Disclose
 
Stefano Radaelli
No Relationships to Disclose
 
Dario Callegaro
No Relationships to Disclose
 
Carlo Morosi
No Relationships to Disclose
 
Elena Fumagalli
No Relationships to Disclose
 
Paola Collini
No Relationships to Disclose
 
Paolo Giovanni Casali
Research Funding - Advenchen Laboratories (Inst); Amgen/Dompé (Inst); Arog (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Daiihi Sankyo (Inst); Deciphera (Inst); Eisai (Inst); Epizyme (Inst); Fogorn Ther Inc (Inst); GlaxoSmithKline (Inst); Hutchinson MediPharam Lt (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PTC Ther (Inst); Rain Therapeutics (Inst); SpringWorks Ther (Inst)
 
Alessandro Gronchi
Honoraria - Deciphera; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar; SpringWorks Therapeutics
Research Funding - Nanobiotix (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar